XiDrone vs. Fortem Technologies: Counter-UAS Patent Dispute Settles in Utah District Court
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | XiDrone Systems, Inc. v. Fortem Technologies, Inc. |
| Case Number | 2:24-cv-00905 (D. Utah) |
| Court | U.S. District Court for the District of Utah |
| Duration | Dec 2024 – Oct 2025 307 days |
| Outcome | Confidential Settlement |
| Patents at Issue | |
| Accused Products | Fortem DroneHunter F700, TrueView Radars, SkyDome Manager, etc. |
Case Overview
Introduction
A confidential settlement has closed one of the more closely watched counter-drone patent infringement disputes in recent memory. XiDrone Systems filed suit against Fortem Technologies in Utah’s federal district court on December 6, 2024, alleging infringement of U.S. Patent No. 12,092,756 B1—a patent covering unmanned aerial system (UAS) interdiction technology. Within 307 days, the parties resolved the matter without a public verdict, notifying the court on October 9, 2025, that a confidential settlement had been reached.
The case carries significant weight for the rapidly expanding counter-UAS market, where commercial and defense-oriented companies are racing to protect proprietary airspace security innovations. For patent attorneys, IP professionals, and R&D teams operating in the drone detection and neutralization space, this litigation offers instructive lessons about assertion strategy, competitive risk, and the practical dynamics of settling patent disputes involving national-security-adjacent technology.
Primary keyword alignment: counter-drone patent infringement, UAS interdiction patent litigation
The Parties
⚖️ Plaintiff
Developer of RF deterrent technology targeting unauthorized drone activity, focusing on electronic countermeasures for neutralizing unmanned aerial threats.
🛡️ Defendant
Prominent counter-UAS market player offering a comprehensive airspace security platform, including radar, AI detection, and interceptor drones.
Patents at Issue
The core of the dispute was U.S. Patent No. 12,092,756 B1 (application number US18/439,171), covering technology related to systems and methods for interdicting unmanned aerial targets. Its claims broadly address detecting, tracking, and neutralizing rogue drones—the functional core of Fortem’s commercial offerings.
Accused Products
XiDrone’s complaint named a substantial portion of Fortem’s product ecosystem, indicating a broad infringement theory:
- • Fortem DroneHunter F700 – autonomous interceptor drone
- • Fortem TrueView R20 and R30 Radars – detection and tracking systems
- • Fortem TrueView C30 Camera System – visual acquisition hardware
- • Fortem Edge Fusion System – sensor data integration platform
- • Fortem SkyDome Manager – overarching airspace management software
- • Fortem’s System for Interdicting an Unmanned Aerial Target
Developing counter-UAS technology?
Ensure your innovations don’t infringe existing patents like US 12,092,756 B1.
The Settlement & Legal Analysis
Outcome
The case terminated via confidential settlement—the parties’ joint notice confirmed a binding agreement and requested removal of all pending calendar deadlines. Specific financial terms, licensing arrangements, and any injunctive components were not disclosed. This is characteristic of counter-UAS and defense-adjacent IP disputes, where commercial sensitivity and national security considerations often motivate confidentiality.
Verdict Cause Analysis
The sole stated cause of action was patent infringement under 35 U.S.C. § 271. No claim construction order or summary judgment rulings were issued prior to settlement. The breadth of accused products suggests XiDrone pursued a platform-level infringement theory touching nearly every layer of Fortem’s integrated airspace security stack.
Filing a patent in UAS technology?
Learn from this case. Use AI to draft stronger claims that can withstand scrutiny.
Power Your Patent Strategy with Eureka IP
From novelty searches to patent drafting, Eureka’s AI-powered tools help you navigate the patent landscape with confidence.
⚠️ Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in the counter-UAS market. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation, even with its confidential outcome.
- View patents related to UAS interdiction technology
- See companies active in drone defense IP
- Understand assertion strategy patterns
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own counter-UAS technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Integrated counter-UAS platforms
B1 Patent Issued
No prior publication, harder to find
Settlement Driven
Confidential terms, no public precedent
✅ Key Takeaways
For Patent Holders & Litigators
Asserting patents against an entire product ecosystem increases settlement leverage and signal strength.
Search related case law →B1 patents (issued without prior publication) can complicate opponent’s prior art searches, a tactical prosecution consideration.
Explore B1 patent strategies →For Accused Infringers & R&D Teams
Early engagement of dual counsel (local & national) is critical for defending multi-product platform assertions.
Assess your IP risk →FTO for counter-UAS platforms must account for integrated systems and newly issued B1 patents.
Start FTO analysis for my product →Ready to Strengthen Your Patent Strategy?
Join thousands of IP professionals using Eureka to conduct prior art searches, draft patents, and analyze competitive landscapes.
📑 Table of Contents
🚀 Eureka IP Tools
🔍Novelty Search
Find prior art instantly
Patent Drafting
AI-assisted claim writing
FTO Analysis
Assess infringement risk
Concerned About Your Counter-UAS Product?
Don’t wait for litigation. Check your product’s freedom to operate now.
Run FTO for My Product⚡ Accelerate Your IP Strategy
Join 15,000+ IP professionals using Eureka for patent research and analysis.